PINK1/Parkin-mediated mitophagy in neurodegenerative diseases

J Li, D Yang, Z Li, M Zhao, D Wang, Z Sun, P Wen… - Ageing research …, 2023 - Elsevier
Mitochondria play key roles in bioenergetics, metabolism, and signaling; therefore, stable
mitochondrial function is essential for cell survival, particularly in energy-intensive neuronal …

PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson's disease

P Ge, VL Dawson, TM Dawson - Molecular neurodegeneration, 2020 - Springer
That certain cell types in the central nervous system are more likely to undergo
neurodegeneration in Parkinson's disease is a widely appreciated but poorly understood …

Key genes and convergent pathogenic mechanisms in Parkinson disease

R Coukos, D Krainc - Nature Reviews Neuroscience, 2024 - nature.com
Parkinson disease (PD) is a neurodegenerative disorder marked by the preferential
dysfunction and death of dopaminergic neurons in the substantia nigra. The onset and …

Mitophagy: molecular mechanisms, new concepts on parkin activation and the emerging role of AMPK/ULK1 axis

R Iorio, G Celenza, S Petricca - Cells, 2021 - mdpi.com
Mitochondria are multifunctional subcellular organelles essential for cellular energy
homeostasis and apoptotic cell death. It is, therefore, crucial to maintain mitochondrial …

[HTML][HTML] PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease

JH Shin, HS Ko, H Kang, Y Lee, YI Lee, O Pletinkova… - Cell, 2011 - cell.com
A hallmark of Parkinson's disease (PD) is the preferential loss of substantia nigra dopamine
neurons. Here, we identify a new parkin interacting substrate, PARIS (ZNF746), whose …

[HTML][HTML] Mitophagy in Alzheimer's disease and other age-related neurodegenerative diseases

Q Cai, YY Jeong - Cells, 2020 - mdpi.com
Mitochondrial dysfunction is a central aspect of aging and neurodegenerative diseases,
including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and …

Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences

N Exner, AK Lutz, C Haass, KF Winklhofer - The EMBO journal, 2012 - embopress.org
Neurons are critically dependent on mitochondrial integrity based on specific morphological,
biochemical, and physiological features. They are characterized by high rates of metabolic …

Structure of parkin reveals mechanisms for ubiquitin ligase activation

JF Trempe, V Sauvé, K Grenier, M Seirafi, MY Tang… - Science, 2013 - science.org
Mutations in the PARK2 (parkin) gene are responsible for an autosomal recessive form of
Parkinson's disease. The parkin protein is a RING-in-between-RING E3 ubiquitin ligase that …

[HTML][HTML] New avenues for the treatment of Huntington's disease

A Kim, K Lalonde, A Truesdell, P Gomes Welter… - International journal of …, 2021 - mdpi.com
Huntington's disease (HD) is a neurodegenerative disorder caused by a CAG expansion in
the HD gene. The disease is characterized by neurodegeneration, particularly in the striatum …

Ferroptosis and cell death mechanisms in Parkinson's disease

SJ Guiney, PA Adlard, AI Bush, DI Finkelstein… - Neurochemistry …, 2017 - Elsevier
Symptoms of Parkinson's disease arise due to neuronal loss in multiple brain regions,
especially dopaminergic neurons in the substantia nigra pars compacta. Current therapies …